Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease. - Forst,T.; Karagiannis,E.; Lubben,G.; Hohberg,C.; Schondorf,T.; Dikta,G.; Drexler,M.; Morcos,M.; Danschel,W.; Borchert,M.; Pfützner,A. (Atherosclerosis, 2008)